Shenzhen Dafo Pharmaceutical

Shenzhen Dafo Pharmaceutical is a Chinese pharmaceutical company specializing in the development and manufacturing of respiratory and ENT (Ear, Nose, Throat) medications. Founded in 1994 and headquartered in Shenzhen, the company is recognized for its expertise in inhalation drug delivery systems, including metered-dose aerosols and nasal sprays. Its product portfolio features treatments for asthma, allergic rhinitis, and COPD, such as Mometasone Furoate and Salbutamol Sulfate. Dafo Pharmaceutical operates GMP-certified manufacturing facilities and is listed on the National Equities Exchange and Quotations (NEEQ) in China. The company focuses on high-barrier generic drugs and improved formulations to serve the domestic Chinese market.